// App-Quantinova.ai

: CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): A Large Real-World Series from Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Researchers

Presenter

  • Eolia Brissot

Principal Investigators

  • Myriam Labopin

  • Federico Lussana

  • Rachael Hough

  • Jurgen Kuball

  • Wolf Roesler

  • Sabine Furst

  • Pere Barba

  • Michael Daskalakis

  • Tayfun Gungor

  • Marc Bierings

  • Caroline Besley

  • Ioanna Sakellari

  • Dimitrios Karakasis

  • Mi Kwon

  • Nathalie Fegueux

  • Annalisa Ruggeri

  • Christian Chabannon

  • Sebastian Giebel

  • Zinaida Peric

  • Arnon Nagler

  • Fabio Ciceri

  • Mohamad Mohty

Medical Centers

  • Hematology Department, Institut Paoli-Calmettes, Marseille, France

  • Hematology and Bone Marrow Transplant Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel

  • University College London Hospital, London, United Kingdom

  • University Hospital Erlangen, Erlangen, GERMANY

  • Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

  • Division of Stem Cell Transplantation, The Hospital of the Eleonore Fondation,University Children`s Hospital, ZüRich, Switzerland

  • Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy

  • EBMT Paris study office / CEREST-TC, Paris, France, Department of Hematology, Saint Antoine Hospital, Paris, France, INSERM UMR , Sorbonne University, Paris, France

  • University Hospital Centre Zagreb, Zagreb, CROATIA

  • Department of Hematology, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

  • Evangelismos General Hospital, Department of Haematology and Bone Marrow Transplantation Unit, Athens, Greece

  • Service d'Hématologie Clinique et de Thérapie Cellulaire, Hospital Saint Antoine, Paris Cedex , France

  • Department of Hematology, - University Hospital Bern, Paediatric Hematology/Oncology Insel Gruppe AG, Kreditorenbuchhaltung, Freiburgst, Bern, Switzerland

  • EBMT Paris study office; Department of Haematology, Saint Antoine Hospital; INSERM UMR , Sorbonne University, Paris, France

  • Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy

  • IRCCS San Raffaele Scientific Institute, Hematology and Bone Marrow Transplant Unit, Milan, Italy

  • Department of Hematology, UMC Utrecht, Utrecht, Netherlands

  • Hematology Department and HCT Unit, George Papanikolaou General Hospital, Thessaloniki, Greece

  • University Hospitals Bristol, Bristol, United Kingdom

  • Department of Hematology, Hospital General Universitario Gregorio Marañón, Gregorio Marañon Health Research Institute, Madrid, Spain

  • Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sklodowska-Curie Cancer Center and Institute of Oncology, Gliwice, Poland

  • Cell Therapy Facility, Institut Paoli-Calmettes, Marseille, France

  • Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

  • Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France

  • Acute Leukemia Working Party of EBMT, Paris, France

  • Department of Clinical Hematology and Cellular Therapy, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne Université, Paris, France

Locations

  • France

  • Spain

  • Israel

  • Poland

  • Italy

  • Croatia

  • United Kingdom

  • Germany

  • Netherlands

  • Greece

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • B-cell acute lymphoblastic leukemia

  • Acute Leukemia

Biomarkers

  • Cluster of Differentiation 19

Drug/Treatment

  • tisagenlecleucel-t

Outcome

  • N/A

Study Design

  • Efficacy

  • Safety

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved